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NDP001:
EXTENDED LYMPHADENECTOMY IMPROVES THE PROGNOSIS OF THE
PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER: ANALYSIS
FROM THE NATIONWIDE CANCER REGISTRY DATABASE
Teng-Kai Yang 1, Chung-Hsin Chen 2, Wen-Jeng Wu3. 1 Surgery department,
Yonghe Cardinal Hospital, New Taipei city, Taiwan; 2Department of Urology,
National Taiwan University Hospital, Taipei, Taiwan; 3Kaohsiung Municipal
Ta-Tung Hospital, Kaohsiung, Taiwan
Purpose: This study was designed to assess the impact of the number of
dissected lymph nodes (LNs) on overall survival (OS) and cancer speciﬁc
survival (CSS) in patients undergoing radical cystectomy (RC) for bladder
cancer.
Materials and Methods: From 2008 to 2013, 289 patients undergoing RC
for treating muscle invasive bladder urothelial carcinoma staging T2-4N0
were selected from Taiwan cancer registry database. The number of
removed LNs, age, gender, pathological grade and stage, and pre-operative
image ﬁndings were assessed. The Cox proportional hazard model was
used to evaluate the impact of the number of removed LNs on overall
survival (OS) and cancer speciﬁc survival (CSS).
Results: After stratifying patients by the number of removed LNs, we
discovered there were no signiﬁcant differences of tumor stages, grade,
age, and gender. In multivariate regression models, after the adjust-
ment of age, gender, pathological grade and pathological stage, there
was a statistically signiﬁcant improvement OS (HR: 0.40; 95% CI:
0.20e0.82) and CSS (HR: 0.58; 95% CI: 0.36e0.92) in the patients who
had dissected LNs of more than 10 compared to those with fewer
dissected LNs.
Conclusion: In patients undergoing RC, dissected LNs of more than 10 was
associated with a signiﬁcantly better OS and CSS. That indicated an
extended lymphadenectomy would be helpful for improving patients’
prognosis.
NDP002:
PATIENTS WITH PATHOLOGICAL T3 PROSTATE CANCER TREATED WITH
ROBOT-ASSISTED RADICAL PROSTATECTOMY e A SINGLE INSTITUE
EXPERIENCE
Seng-Tang Wu, Chien-Chang Kao, Chu-Wei Tsao, Shou-Hung Tang, En
Meng, Guang-Huan Sun, Dah-Shyong Yu, Pao-Luo Fan, Sun-Yran Chang,
Tai-Lung Cha. Division of Urology, Department of Surgery, Tri-Service
General Hospital, National Defense Medical Center, Taipei, Taiwan
Purpose: We analyzed the surgical results of prostate cancer in patients
who had pT3 disease were treated by robot-assisted radical prostatectomy
(RARP) at our hospital.
Materials and Methods: There were over 500 prostate cancers had been
treated by RARP at our institution. We review 363 consecutive patients
who underwent RARP by a single surgeon from September 2009 to
February 2015. Peri- and post-operative data were collected and analyzed
for all patients.
Results: In total, 363 consecutive patients underwent RARP. Seven patients
with distant metastases at diagnosis, had neoadjuvant therapy and path-
ological T0 disease were excluded. Of these 356 patients, the mean agewas65.2 years, the mean pre-operative PSA was 10.2 ng/mL. 123 (34.6%) pa-
tients with mean age 65.9 and mean pre-operative PSA 13.9 ng/mL were
found to have pT3 disease, including pT3a in 80 and pT3b in 43 cases. The
PSM rate for patients with pT3 diseasewas 56.2%. The PSM rate for patients
with pT3a and pT3b disease was 51.3% and 39.5%, respectively. Comparing
pT3 with pT2 cases, the patient’s age, prostate weight were no different.
The pT3 group had higher mean pre-operative PSA level (13.4 vs 22.3 ng/
mL), percentage of tumor volume (14.4% vs 22.3%), positive margin rates
(9.9% vs 54.5%), biopsy and prostatectomy specimen Gleason score (6.7 vs
7.3, and 7.0 vs 7.4). 37 (30.1%) in 109 pT3 patients with biochemical
recurrence (BCR), time to BCR was 24 months. Biopsy Gleason score is the
only independent preoperative predictor of BCR in pT3a cases. Biopsy
Gleason and preoperative PSA are the only independent preoperative
predictors of BCR in pT3b RARP cases.
Conclusion: We present the results of the treatment for locally
advanced prostate cancer initially managed with RARP. Our ﬁndings
suggest that patients with locally advanced prostate cancer can be
treated with RARP with higher but acceptable positive margin rates and
surgical results.
NDP003:
TREND OF GLOBAL QUALITY OF LIFE IN LOCALIZED OR METASTATIC
PROSTATE CANCER PATIENTS AFTER TREATMENT
Yao-Lin Kao 1, Yuh-Shyan Tsai 1, Zong-Ying Lin 2, Chien-Hui Ou 1,
Wen-Horng Yang 1, Hong-Lin Chen 1, Tzong-Shin Tzai 1, Jung-Der Wang 2.
1Department of Urology, Medical College and Hospital, National Cheng
Kung University, Tainan, Taiwan; 2Department of Public Health, Medical
College and Hospital, National Cheng Kung University, Tainan, Taiwan
Purpose: Quality of life (QoL) is an important concern in prostate cancer
(PC) treatment, particularly facing with selection of any optimal therapy.
The trend of global QoL may help physician and patients in decision
making for treatment strategy. The aim of the study is to explore the trend
of global QoL after standard treatments in PC patients with localized or
metastatic diseases.
Materials and Methods: From January 2013 to April 2015, self-reported
questionnaires, World Health Organization Quality of Life-BREF (WHO-
QOL-BREF) serving as a tool for global QoL assessment with good validity
and reliability, were randomly obtained from prostate cancer patients at
urologic outpatient clinic. Repeated measurements in same individuals
were obtained from some individuals at different times during follow-up.
The mix-effect model was used for analyzing the determinant of global
QoL and a Kernel smoothing curve ﬁtting was used for analyzing the trend
of global QoL in the initial 5-year follow-up.
Results: A total of 287 patients and 526 person-times completed the
WHOQOL-BREF questionnaire with a mean age of 72.7 years, including
localized disease (n¼ 156) and metastatic disease (n¼ 131). The analysis
of the Kernel smooth curve showed decreases of global QoL in physical,
psychological and social domains in localized disease patients after
receiving radical prostatectomy or radiotherapy compare to active sur-
veillance group, both of which gradually recovered in one and half a year.
In contrast, metastatic patients exhibited both increases of global QoL in
physical and psychological domains after androgen deprivation therapy
or palliative radiotherapy as compared with watchful and supportive
groups (Figure 1). Moreover, radiotherapy is an independent risk factor
